An Observation Study to Assess the Efficacy and Safety of Proportional Doses of Painkyl® in Patients With Breakthrough Cancer Pain
An open-label, single arm, observation study, to assess the efficacy and safety of proportional doses of Painkyl® in patients with breakthrough cancer pain.
Cancer Pain
DRUG: Fentanyl Buccal Soluble Film
Percentage of patients requiring dose titration, Percentage of patients requiring dose titration, At study end (at least 30 subjects completed 2 doses of study treatment without dose titration), around 4 years
Pain intensity changes at 5, 10, 15, 30 minutes after dosing, Pain score at 5, 10, 15, 30 minutes after dosing vs. pain score before dosing. Pain scale (0-10, 0=no pain to 10=worst pain) will be recorded by subject at the time point of before Painkyl dosing, and at 5, 10, 15, 30 minutes after dosing., At study end (at least 30 subjects completed 2 doses of study treatment without dose titration), around 4 years|Subjects' satisfaction, Subjects' satisfaction (poor, fair, good, very good, excellent) will be recorded by subject for at least 2 assessment, At study end (at least 30 subjects completed 2 doses of study treatment without dose titration), around 4 years
An open-label, single arm, observation study, to assess the efficacy and safety of proportional doses of Painkyl® in patients with breakthrough cancer pain.